Marjorie Illingworth

820 total citations
8 papers, 239 citations indexed

About

Marjorie Illingworth is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Marjorie Illingworth has authored 8 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Genetics and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Marjorie Illingworth's work include RNA modifications and cancer (3 papers), Cardiomyopathy and Myosin Studies (3 papers) and Neurogenetic and Muscular Disorders Research (3 papers). Marjorie Illingworth is often cited by papers focused on RNA modifications and cancer (3 papers), Cardiomyopathy and Myosin Studies (3 papers) and Neurogenetic and Muscular Disorders Research (3 papers). Marjorie Illingworth collaborates with scholars based in United Kingdom, Australia and United States. Marjorie Illingworth's co-authors include Manju A. Kurian, Marissa King, Jessica Taytard, M. Annoussamy, Mariacristina Scoto, Chiara Marini‐Bettolo, Adnan Y. Manzur, R. T. Younis, Carole Vuillerot and Mondher Chouchane and has published in prestigious journals such as Neurology, Developmental Medicine & Child Neurology and Molecular Genetics and Metabolism.

In The Last Decade

Marjorie Illingworth

7 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marjorie Illingworth United Kingdom 5 142 93 65 57 54 8 239
Karen L. Kline United States 10 108 0.8× 19 0.2× 64 1.0× 23 0.4× 29 0.5× 16 248
Marsela Qesari Italy 5 157 1.1× 16 0.2× 77 1.2× 19 0.3× 37 0.7× 5 339
Kouki Makioka Japan 10 98 0.7× 34 0.4× 8 0.1× 158 2.8× 54 1.0× 34 296
Colleen F. Stevens United States 7 166 1.2× 160 1.7× 111 1.7× 53 0.9× 18 0.3× 11 337
C.M. Reilly Australia 4 58 0.4× 87 0.9× 37 0.6× 157 2.8× 28 0.5× 8 271
Thiloka Ratnaike United Kingdom 8 277 2.0× 9 0.1× 47 0.7× 30 0.5× 16 0.3× 13 397
Antonio Milano United Kingdom 7 28 0.2× 40 0.4× 8 0.1× 104 1.8× 29 0.5× 9 169
Ratna Bhavaraju‐Sanka United States 5 120 0.8× 13 0.1× 44 0.7× 62 1.1× 12 0.2× 10 206
Chris Rittey United Kingdom 9 76 0.5× 23 0.2× 8 0.1× 16 0.3× 18 0.3× 13 186
Mitsuo Motobayashi Japan 10 62 0.4× 13 0.1× 12 0.2× 31 0.5× 25 0.5× 35 228

Countries citing papers authored by Marjorie Illingworth

Since Specialization
Citations

This map shows the geographic impact of Marjorie Illingworth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjorie Illingworth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjorie Illingworth more than expected).

Fields of papers citing papers by Marjorie Illingworth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marjorie Illingworth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjorie Illingworth. The network helps show where Marjorie Illingworth may publish in the future.

Co-authorship network of co-authors of Marjorie Illingworth

This figure shows the co-authorship network connecting the top 25 collaborators of Marjorie Illingworth. A scholar is included among the top collaborators of Marjorie Illingworth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marjorie Illingworth. Marjorie Illingworth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Childs, Anne‐Marie, Elizabeth Wraige, Pinki Munot, et al.. (2024). Risdiplam in Spinal Muscular Atrophy: Safety Profile and Use Through The Early Access to Medicine Scheme for the Paediatric Cohort in Great Britain. Journal of Neuromuscular Diseases. 11(2). 361–368. 5 indexed citations
2.
Phadke, Rahul, Anna Sárközy, Emily C. Oates, et al.. (2019). P.236Myofibres with subsarcolemmal rims and/or central aggregates of mitochondria (SRCAM) are prevalent in congenital titinopathies. Neuromuscular Disorders. 29. S135–S135.
3.
Oates, Emily C., Sandra Coppens, Madhura Bakshi, et al.. (2018). CONGENITAL MYOPATHIES: NEMALINE AND TITINOPATHIES. Neuromuscular Disorders. 28. S104–S104. 1 indexed citations
4.
Daron, Aurore, Carole Vuillerot, Claude Cancés, et al.. (2018). Nusinersen in patients older than 7 months with spinal muscular atrophy type 1. Neurology. 91(14). e1312–e1318. 86 indexed citations
5.
Singh, Jaspal, Marjorie Illingworth, Andrea Whitney, et al.. (2015). Spinal Muscular Atrophy-Lower Extremity Dominant (SMA-LED), with bilateral perisylvian polymicrogyria and infantile epileptic encephalopathy, due a novel DYNC1H1 mutation. Neuromuscular Disorders. 25. S222–S223. 3 indexed citations
6.
Illingworth, Marjorie, Marion Main, Matthew Pitt, et al.. (2014). RYR1-related congenital myopathy with fatigable weakness, responding to pyridostigimine. Neuromuscular Disorders. 24(8). 707–712. 31 indexed citations
7.
Illingworth, Marjorie, Esther Meyer, W.K. Chong, et al.. (2014). PLA2G6-associated neurodegeneration (PLAN): Further expansion of the clinical, radiological and mutation spectrum associated with infantile and atypical childhood-onset disease. Molecular Genetics and Metabolism. 112(2). 183–189. 69 indexed citations
8.
Illingworth, Marjorie, Donncha Hanrahan, Jennifer J. Anderson, et al.. (2011). Elevated VGKC-complex antibodies in a boy with fever-induced refractory epileptic encephalopathy in school-age children (FIRES). Developmental Medicine & Child Neurology. 53(11). 1053–1057. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen L. Kline Breakdown of academic impact, for papers by Marsela Qesari Breakdown of academic impact, for papers by Kouki Makioka Breakdown of academic impact, for papers by Colleen F. Stevens Breakdown of academic impact, for papers by C.M. Reilly Breakdown of academic impact, for papers by Thiloka Ratnaike Breakdown of academic impact, for papers by Antonio Milano Breakdown of academic impact, for papers by Ratna Bhavaraju‐Sanka Breakdown of academic impact, for papers by Chris Rittey Breakdown of academic impact, for papers by Mitsuo Motobayashi
Rankless by CCL
2026